Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
20
2016
FDA Extends Deadline for Removal of NDC and NHRIC Numbers from Device Labeling and Packaging McDermott Will & Emery
Sep
20
2016
FDA Announces Public Hearing on Off-Label Communications; Registration Deadline October 19, 2016 McDermott Will & Emery
Sep
20
2016
Antibiotic Ire: Groups Petition FDA to Limit Antibiotic Use in Food Animals Keller and Heckman LLP
Sep
20
2016
Court of Appeals for the Federal Circuit Says Functional Claim Language Does Not Create Divided Infringement Foley & Lardner LLP
Sep
20
2016
Eight States Will Vote On New Marijuana Laws On Election Day 2016 Jackson Lewis P.C.
Sep
19
2016
FDA Holds Public Hearing and Seeks Comment on Draft Guidances Concerning Regulation of HCT/Ps Covington & Burling LLP
Sep
19
2016
FDA Issues Parts 1-5 of 14-Part Draft Guidance for Preventive Controls Final Rule Morgan, Lewis & Bockius LLP
Sep
19
2016
EPA, FDA, and USDA Release Updates to Coordinated Framework on Biotechnology Bergeson & Campbell, P.C.
Sep
19
2016
Continuing Resolution and Zika Negotiations Persist, Vote Could Occur Early This Week Squire Patton Boggs (US) LLP
Sep
19
2016
FDA Issues Guidance for the Labeling of Infant Formula Keller and Heckman LLP
Sep
18
2016
In Re Reglan Litigation: New Jersey Supreme Court Holds that Failure to Timely Update Claims against Generic Drug Manufacturers Are Not Pre-Empted by Federal Law Sills Cummis & Gross P.C.
Sep
16
2016
FDA Concludes Two-Day Public Hearing on Human Cell and Tissue Product (HCT/P) Regulatory Paradigm Mintz
Sep
16
2016
TSCA Update September 16, 2016: Federal Issues; FDA; EPA; FDA Bans Antiseptics, EPA Extends Comment Period On PIPs Bergeson & Campbell, P.C.
Sep
16
2016
E-Cigarette Explodes in Woman’s Purse Stark & Stark
Sep
16
2016
FDA Begins Enforcement of New Tobacco Rules Keller and Heckman LLP
Sep
16
2016
DEA Classifies U-47700, or “Pink”, As A Schedule I Drug Jackson Lewis P.C.
Sep
15
2016
New Survey Shows Positive Workplace Drug Test Results Are On The Rise, Especially For Heroin, Marijuana and Amphetamines Jackson Lewis P.C.
Sep
15
2016
FDA Seeks More Information on Antimicrobials in Animal Feed and Water Keller and Heckman LLP
Sep
15
2016
Sixth Circuit Court Dismisses Claims of Plaintiff Subject to Tart Cherry Order: Leaving a Tart Taste in the Mouth Varnum LLP
Sep
15
2016
Apotex Biosimilar Cleared Of Infringement But Pre-Marketing Notice Still Required Foley & Lardner LLP
Sep
14
2016
FDA Draft Guidance Tightens Requirements for New Dietary Ingredients Morgan, Lewis & Bockius LLP
Sep
14
2016
Money Behind the Battle Over Raising California’s Cigarette Tax MapLight
Sep
14
2016
FDA Begins to Deputize States Under Food Safety Modernization Act Keller and Heckman LLP
Sep
14
2016
Triclosan is Not GRAS/GRAE in OTC Antiseptic Products, Says FDA Keller and Heckman LLP
Sep
13
2016
USDA Issues RFI to Support Development of New GMO Labeling Law Keller and Heckman LLP
Sep
12
2016
EPA Requests Six Month Extension of Deadline for Decision on Chlorpyrifos Tolerance Revocation Bergeson & Campbell, P.C.
Sep
12
2016
Bus Mechanic Who Uses Adderall for ADHD Can Proceed with Disability Discrimination Claims Jackson Lewis P.C.
Sep
12
2016
California's Proposition 65: All Eyes on Aspartame Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins